Literature DB >> 1914836

Effects of the treatment with matrix on elderly people with chronic articular degeneration.

U Oliviero1, G P Sorrentino, P De Paola, E Tranfaglia, A D'Alessandro, S Carifi, F A Porfido, R Cerio, A M Grasso, D Policicchio.   

Abstract

Clinical trials have been conducted to evaluate the effectiveness of Matrix in osteoarthritis, mainly as regards the advantages offered by its physiological mechanism of action. The experiment, lasting 6 months, was performed on two hundred patients in four different Hospital Departments and one University Center. The results showed a considerable improvement both in pain and in mobility. No relevant side effects were found; only 3% of patients, with oral administration, noticed slight nausea and found it necessary to interrupt treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1914836

Source DB:  PubMed          Journal:  Drugs Exp Clin Res        ISSN: 0378-6501


  4 in total

Review 1.  Chondroitin for osteoarthritis.

Authors:  Jasvinder A Singh; Shahrzad Noorbaloochi; Roderick MacDonald; Lara J Maxwell
Journal:  Cochrane Database Syst Rev       Date:  2015-01-28

2.  Analysis of glycosaminoglycans in human serum after oral administration of chondroitin sulfate.

Authors:  A Baici; D Hörler; B Moser; H O Hofer; K Fehr; F J Wagenhäuser
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

Review 3.  Re-appraising the potential of naringin for natural, novel orthopedic biotherapies.

Authors:  Kristin E Yu; Kareme D Alder; Montana T Morris; Alana M Munger; Inkyu Lee; Sean V Cahill; Hyuk-Kwon Kwon; JungHo Back; Francis Y Lee
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-12-08       Impact factor: 5.346

4.  Intra-articular delivery of chondroitin sulfate for the treatment of joint defects in rabbit model.

Authors:  James H Hui; Shzu-Wei Chan; Jun Li; James C H Goh; Li Li; X F Ren; Eng Hin Lee
Journal:  J Mol Histol       Date:  2007-07-25       Impact factor: 3.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.